{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T04:29:51Z","timestamp":1648873791489},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:00:00Z","timestamp":1545350400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00347-018-0839-1","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T12:46:02Z","timestamp":1545396362000},"page":"850-856","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hat der Mikropulslaser bei chronischer CCS einen Effekt?"],"prefix":"10.1007","volume":"116","author":[{"given":"N.-A.","family":"Striebe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Feltgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. H.","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Spier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Callizo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bemme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hoerauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"van Oterendorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,21]]},"reference":[{"key":"839_CR1","first-page":"51","volume":"302","author":"R Brinkmann","year":"2006","unstructured":"Brinkmann R, Roider J, Birngruber R (2006) Selective Retina Therapy (SRT): a\u00a0review on methods, techniques, preclinical and first clinical results. Bull Soc Belge Ophtalmol 302:51\u201369","journal-title":"Bull. Soc. Belge Ophtalmol."},{"key":"839_CR2","doi-asserted-by":"publisher","first-page":"82e118","DOI":"10.1016\/j.preteyeres.2015.05.003","volume":"48","author":"A Daruich","year":"2015","unstructured":"Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, Jaisser F, Behar-Cohen F (2015) Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res 48:82e118","journal-title":"Prog Retin Eye Res"},{"key":"839_CR3","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","volume":"125","author":"E Djik Van","year":"2018","unstructured":"Van Djik E et al (2018) Half-dose photodymamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopahy. Ophthalmology 125:1547\u20131555","journal-title":"Ophthalmology"},{"key":"839_CR4","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2147\/OPTH.S87499","volume":"9","author":"AH Elhamid","year":"2015","unstructured":"Elhamid AH (2015) Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy. Clin Opthalmol 9:2277\u20132283","journal-title":"Clin Opthalmol"},{"key":"839_CR5","doi-asserted-by":"crossref","first-page":"729792","DOI":"10.1155\/2015\/729792","volume":"2015","author":"K Inagaki","year":"2015","unstructured":"Inagaki K, Shuo T, Katakura K, Ebihara N, Murakami A, Ohkoshi K (2015) Sublethal photothermal stimulation with a\u00a0micropulse laser induces heat shock protein expression in ARPE-19 cells. J\u00a0Ophthalmol 2015:729792","journal-title":"J Ophthalmol"},{"key":"839_CR6","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1097\/IAE.0b013e3182445386","volume":"32","author":"K Inagaki","year":"2012","unstructured":"Inagaki K, Ohkoshi K, Ohde S (2012) Spectral-domain optical coherence tomography imaging of retinal changes after conventional multicolor laser, subthreshold micropulse diode laser, or pattern scanning laser therapy in Japanese with macular edema. Retina 32:1592\u20131600","journal-title":"Retina"},{"key":"839_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.exer.2014.04.014","volume":"124","author":"H Iwami","year":"2014","unstructured":"Iwami H, Pruessner J, Shiraki K, Brinkmann R, Miura Y (2014) Protective effect of a\u00a0laser-induced sub-lethal temperature rise on RPE cells from oxidative stress. Exp Eye Res 124:37\u201347","journal-title":"Exp Eye Res"},{"issue":"12","key":"839_CR8","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s00417-015-2965-7","volume":"253","author":"JY Kim","year":"2015","unstructured":"Kim JY, Park HS, Kim SY (2015) Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 253(12):2129\u20132135","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"839_CR9","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s12013-015-0675-8","volume":"73","author":"Z Li","year":"2015","unstructured":"Li Z, Song Y, Chen X, Chen Z, Ding Q (2015) Biological modulation of mouse RPE cells in response to subthreshold diode micropulse laser treatment. Cell Biochem Biophys 73:545\u2013552","journal-title":"Cell Biochem Biophys"},{"key":"839_CR10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/IAE.0000000000000285","volume":"35","author":"KJ Malik","year":"2015","unstructured":"Malik KJ, Sampat KM, Mansouri A, Steiner JN, Glaser BM (2015) Low-intensity\/high-density subthreshold micropulse diode laser for chronic central serous chorioretinopathy. Retina 35:532\u2013536","journal-title":"Retina"},{"key":"839_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/bjo.84.1.40","volume":"84","author":"J Roider","year":"2000","unstructured":"Roider J, Brinkmann R, Wirbelauer C, Laqua H, Birngruber R (2000) Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a\u00a0pilot study. Br J Opthalmol 84:40\u201347","journal-title":"Br J Opthalmol"},{"key":"839_CR12","doi-asserted-by":"publisher","first-page":"8643","DOI":"10.1073\/pnas.90.18.8643","volume":"90","author":"J Roider","year":"1993","unstructured":"Roider J, Hillenkamp F, Flotte T, Birngruber R (1993) Microphotokoagulation: selective effects of repetitive short laser pulses. Proc Natl Acad Sci U S A 90:8643\u20138647","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"839_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000439600","volume":"234","author":"P Scholz","year":"2015","unstructured":"Scholz P, Ersoy L, Boon C, Fauser S (2015) Subthreshold micropulse laser (577\u202fnm) treatment in chronic central serous chorioretinopathy. Ophthalmologica 234:189\u2013194","journal-title":"Ophthalmologica"},{"issue":"11","key":"839_CR14","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3928\/23258160-20161031-01","volume":"47","author":"S Shah","year":"2016","unstructured":"Shah S, Hariprasad SM (2016) Application of micropulse lasers in treating macular diseases. Ophthalmic Surg Lasers Imaging Retina 47(11):985\u2013990","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"839_CR15","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s00417-018-4086-6","volume":"256","author":"V Sheptulin","year":"2018","unstructured":"Sheptulin V, Purtskhvanidze K, Roider J (2018) Half-time photodynamic therapy in treatment of chronic central serous chorioretinopathy. Albrecht Von Graefes Arch Klin Exp Ophthalmol 256:2027\u20132034","journal-title":"Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol."},{"key":"839_CR16","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1097\/IAE.0000000000000521","volume":"35","author":"S Vujosevic","year":"2015","unstructured":"Vujosevic S, Martini F, Longhin E, Convento E, Cavarzeran F, Midena E (2015) Subthreshold micropulse yellow laser versus subthreshold micropulse infrared laser in center-involving diabetic macula edema. Retina 35:1594\u20131603","journal-title":"Retina"},{"key":"839_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/eye.2014.315","volume":"29","author":"NK Yadav","year":"2015","unstructured":"Yadav NK, Jayadev C, Mohan A, Vijayan P, Battu R, Dabir S, Shetty B, Shetty R (2015) Subthreshold micropulse yellow laser (577\u202fnm) in chronic central serous chorioretinopathy: safety profile and treatment outcome. Eye 29:258\u2013265","journal-title":"Eye"},{"key":"839_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00417-016-3441-8","volume":"255","author":"A Yasui","year":"2017","unstructured":"Yasui A, Yamamoto M, Hirayama K, Shiraki K, Theisen-Kunde D, Brinkmann R, Miura Y, Kohno T (2017) Retinal sensitivity after selective retina therapy (SRT) on patients with central serous chorioretinopathy. Albrecht Von Graefes Arch Klin Exp Ophthalmol 255:243\u2013254","journal-title":"Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol."},{"key":"839_CR19","first-page":"2216","volume":"54","author":"AK Yu","year":"2013","unstructured":"Yu AK, Merrill KD, Truong SN, Forward KM, Morse LS, Telander DG (2013) The comparative histologic effects of subthreshold 532- and 810-nm diode micropulse laser on the retina. Retina 54:2216\u20132224","journal-title":"Retina"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-018-0839-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-018-0839-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-018-0839-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T01:09:24Z","timestamp":1605748164000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-018-0839-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,21]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1007\/s00347-018-0839-1","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,21]]},"assertion":[{"value":"21 December 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.\u00a0Hoerauf gibt folgenden Interessenkonflikt an: Forschungsf\u00f6rderung durch Alcon\/Novartis, Allergan, Bayer, Bioeq\/Formycon, Carl Zeiss Meditec, Boehringer Ingelheim, Heidelberg Engineering, Ophthotech, Roche, Lutronic, Regeneron Pharmaceuticals; Referentenhonorar von Alcon\/Novartis, Allergan, Bayer, Heidelberg Engineering, Alimera; Patent\/Gesch\u00e4ftsanteile\/Aktien von Novartis, Roche, 3M, Johnsson &\u00a0Johnsson. N.-A.\u00a0Striebe, N.\u00a0Feltgen, M.H.\u00a0Khattab, L.\u00a0Spier, J.\u00a0Callizo, S.\u00a0Bemme und C.\u00a0van Oterendorp geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Alle beschriebenen Untersuchungen am Menschen wurden mit Zustimmung der zust\u00e4ndigen Ethik-Kommission, im Einklang mit nationalem Recht sowie gem\u00e4\u00df der Deklaration von Helsinki von 1975 (in der aktuellen, \u00fcberarbeiteten Fassung) durchgef\u00fchrt. Von allen beteiligten Patienten liegt eine Einverst\u00e4ndniserkl\u00e4rung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}